Anja Linnemann
About Anja Linnemann
Anja Linnemann is the Senior Director of Global Field Medical Strategy at Bristol Myers Squibb, with over two decades of experience in the pharmaceutical and biotechnology industries.
Current Title at Bristol Myers Squibb
Anja Linnemann currently holds the position of Senior Director Global Field Medical Strategy at Bristol Myers Squibb. Based in the Zürich und Umgebung region, she leads the strategic direction for Field Medical teams across all Therapeutic Areas and regions globally from this role.
Former Roles at Bristol Myers Squibb
Anja Linnemann has held multiple significant roles at Bristol Myers Squibb. From 2014 to 2023, she served as Global Field Medical Director, and earlier, from 2009 to 2014, she was the Disease Area Head for Cardiovascular & Metabolics in EU Markets. Additionally, she took on the role of European Medical Communication Lead Cardiovascular for six months in France in 2009, and from 2007 to 2009, she was a Medical Advisor for Cardiovascular.
Career at Bioptron AG
Before joining Bristol Myers Squibb, Anja Linnemann worked at Bioptron AG, where she cultivated her expertise in scientific coordination. She served first as a Scientific Coordinator from 2000 to 2004 and then progressed to Head of Scientific Coordination from 2004 to 2007.
Educational Background
Anja Linnemann completed her studies in Biology at the University of Hohenheim, specializing in Microbiology, Virology, Biochemistry, Biotechnology, and Physiology. She studied there from 1993 to 2000, achieving her degree in 2000.
Industry Experience
Anja Linnemann has over 20 years of experience in the pharmaceutical and biotechnology industries. Her career spans roles focusing on medical strategy, scientific coordination, and leadership. Her extensive background ensures she brings comprehensive expertise, particularly in cardiovascular and metabolic disease areas.